| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/22/2011 | US7892568 Methods and compositions for detection of Ehrlichia chaffeensis (p120) |
| 02/22/2011 | US7892567 Methods and compositions for immunization against chlamydial infection and disease |
| 02/22/2011 | US7892566 Immunogenic constructs |
| 02/22/2011 | US7892564 Recombinant infectious laryngotracheitis virus and uses thereof |
| 02/22/2011 | US7892563 Methods for treatment of severe acute respiratory syndrome (SARS) |
| 02/22/2011 | US7892562 Methods of inducing TH-1 immune responses to HIV-1 by administering UV/psoralen-treated desialated inactiviated HIV-1 virions deficient in CD55 and CD59 |
| 02/22/2011 | US7892561 Neutralizing GDF8 epitope-based growth enhancing vaccine |
| 02/22/2011 | US7892560 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 02/22/2011 | US7892559 Major histocompatibility complex class I restricted epitope peptide for use in diagnosis, prevention and treament of cell proliferative disorders; antitumor agents |
| 02/22/2011 | US7892558 Isolated TNF-alpha peptide and pharmaceutical composition thereof |
| 02/22/2011 | US7892557 Peptide mimotopes of mycobacterial mannosylated lipoglycans and uses thereof |
| 02/22/2011 | US7892556 Apoptotically active peptides |
| 02/22/2011 | US7892555 Prophylactic and therapeutic immunization against protozoan infection and disease |
| 02/22/2011 | US7892554 Using immunoglobulin fusion to deliver effector cells; tissue targeted therapy; antitumor agents |
| 02/22/2011 | US7892553 Materials and methods to reduce low density lipoprotein cholesterol |
| 02/22/2011 | US7892552 Group B Streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof |
| 02/22/2011 | US7892551 Antibody kit for enumeration of CD4+ lymphocytes |
| 02/22/2011 | US7892550 Anti-cmet antibodies |
| 02/22/2011 | US7892549 Treatment with anti-ErbB2 antibodies |
| 02/22/2011 | US7892548 121P1F1: a tissue specific protein highly expressed in various cancers |
| 02/22/2011 | US7892547 Methods and compositions for administering therapeutic and diagnostic agents |
| 02/22/2011 | US7892546 Anti-CXCR4 antibodies |
| 02/22/2011 | US7892545 Humanized antibodies that sequester amyloid beta peptide |
| 02/22/2011 | US7892544 Humanized anti-beta-amyloid antibody |
| 02/22/2011 | US7892543 Chimeric antibodies; lymphocytes; genetic engineering; for treatment of myeloma |
| 02/22/2011 | US7892542 Human anti-idiotypic antibody fragments that mimic HER-2/neu |
| 02/22/2011 | US7892541 Soluble epidermal growth factor receptor isoforms |
| 02/22/2011 | US7892540 B7-H1 and methods of diagnosis, prognosis, and treatment of cancer |
| 02/22/2011 | US7892539 Modulation of an innate immune response by altering TRIAL-R signaling |
| 02/22/2011 | US7892538 Monovalent ligand of the FcαRI receptor as an anti-inflammatory agent |
| 02/22/2011 | US7892533 Modified vaccinia virus ankara for the vaccination of neonates |
| 02/22/2011 | US7892529 Peptides for active anti-cytokine immunization |
| 02/22/2011 | CA2554195C Peptide originating in epidermal growth factor receptor (egfr) |
| 02/22/2011 | CA2441566C Blood cell production via activation of the hemoglobin scavenger receptor |
| 02/22/2011 | CA2431881C Polypeptide inducing hiv-neutralising antibodies |
| 02/22/2011 | CA2423833C Viruses targeted to hypoxic cells and tissues |
| 02/22/2011 | CA2410193C Neuronal serine-threonine protein kinase |
| 02/22/2011 | CA2404429C Malaria plasmodium antigen polypeptide se36, method of purifying the same and vaccine and diagnostic with the use of the thus obtained antigen |
| 02/22/2011 | CA2399504C Methods for producing temperature-sensitive morbillivirus |
| 02/22/2011 | CA2329772C Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 02/22/2011 | CA2253875C Early detection of lysosomal storage disorders |
| 02/22/2011 | CA2223754C Actinomyces pyogenes and actinomyces pyogenes/fusobacterium necrophorum vaccines for immunizing cattle and sheep |
| 02/22/2011 | CA2143491C A novel peptide related to human programmed cell death and dna encoding it |
| 02/17/2011 | WO2011020095A2 Compositions and methods of treating inflammation |
| 02/17/2011 | WO2011020079A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use |
| 02/17/2011 | WO2011019932A2 Compositions and methods for the therapy and diagnosis of influenza |
| 02/17/2011 | WO2011019679A1 Ccr2 inhibitors for treating conditions of the eye |
| 02/17/2011 | WO2011019423A2 Modulation of pilr receptors to treat microbial infections |
| 02/17/2011 | WO2011019410A1 Ophthalmic drug delivery system containing phospholipid and cholesterol |
| 02/17/2011 | WO2011019399A1 Preservation of blood vessels using phosphodiesterase inhibitors |
| 02/17/2011 | WO2011019323A1 Particulate hyaluronic acid formulations for cellular delivery of bioactive agents |
| 02/17/2011 | WO2011019134A2 Vaccine composition including salmonella microorganism variants for preventing fowl typhoid |
| 02/17/2011 | WO2011019065A1 Tumor angiogenesis inhibitor |
| 02/17/2011 | WO2011018858A1 Novel mastitis vaccine |
| 02/17/2011 | WO2011018779A1 Modified helicobacter protein |
| 02/17/2011 | WO2011018769A1 Use of mycobacterium bovis bcg killed by extended freeze drying (efd) for preventing or treating atherosclerosis |
| 02/17/2011 | WO2011018225A1 Combination therapy of an afucosylated cd20 antibody with fludarabine and/or mitoxantrone |
| 02/17/2011 | WO2011018224A1 Combination therapy of an afucosylated cd20 antibody with bendamustine |
| 02/17/2011 | WO2011018208A1 Human monoclonal antibody against s. aureus derived alpha-toxin and its use in treating or preventing abscess formation |
| 02/17/2011 | WO2011017799A1 Vaccine having a peptide adjuvant for eliciting a specific immune response to treat viral infection and other conditions |
| 02/17/2011 | WO2011017791A1 Monoclonal antibodies against the pbp2-a protein and homologous sequences for the treatment of infections by and immunodiagnostics of bacteria of the firmicutes phylum |
| 02/17/2011 | WO2010146043A3 System for the heterologous expression of a viral protein in a ciliate host cell |
| 02/17/2011 | WO2010138171A9 Methods for cancer treatment using stem cells |
| 02/17/2011 | WO2010135054A3 Mutations in a toll-like receptor motif in the ns4b of classical swine fever virus skin brescia influences virulence in swine |
| 02/17/2011 | WO2010129674A3 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins |
| 02/17/2011 | WO2010123845A3 Siderophore conjugate immunogenic compositions and vaccines |
| 02/17/2011 | WO2010123527A3 Use of epidermal growth factor inhibitors in the treatment of viral infection |
| 02/17/2011 | WO2010108177A3 A method and composition using a dual specificity protein tyrosine phosphatase as an antimalarial drug target |
| 02/17/2011 | WO2010104747A3 Antigen presenting cell targeted vaccines |
| 02/17/2011 | WO2010092176A3 Nontypable haemophilus influenzae antigens |
| 02/17/2011 | WO2010091399A9 Reelin rescues cognitive function |
| 02/17/2011 | WO2010046289A3 Blockers of light, ltalpha1beta2 and ltalpha2beta1 or their receptor ltbetar for the prevention and treatment of chronic hepatitis and other liver diseases |
| 02/17/2011 | WO2009101206A3 Strategies to prevent and/or treat immune responses to soluble allofactors |
| 02/17/2011 | US20110041222 Artificial dna sequence with optimized leader function in 5' (5'-utr) for the improved expression of heterologous proteins in plants |
| 02/17/2011 | US20110040259 Method for allogeneic cell therapy |
| 02/17/2011 | US20110040249 Human Anti-IL-23 Antibodies, Compositions, Methods and Uses |
| 02/17/2011 | US20110040076 Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors |
| 02/17/2011 | US20110038941 Lipid Nanoparticle Compositions and Methods of Making and Using the Same |
| 02/17/2011 | US20110038939 Therapeutic stable nanoparticles |
| 02/17/2011 | US20110038935 Antibodies against influenza virus and methods of use thereof |
| 02/17/2011 | US20110038903 Apparatus and Process for Generating and Harvesting Adult Stem Cells and Fluid Associated with it from Skin and Omentum for Medical, Cosmetic, and Veterinary Use |
| 02/17/2011 | US20110038900 Nanoparticles for use in pharmaceutical compositions |
| 02/17/2011 | US20110038896 Biodegradable immunomodulatory formulations and methods for use thereof |
| 02/17/2011 | US20110038895 Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer |
| 02/17/2011 | US20110038894 Immunogenic Peptides of Tumor Associated Antigen L6 and Uses Thereof in Cancer Therapy |
| 02/17/2011 | US20110038893 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy |
| 02/17/2011 | US20110038892 Complexing system |
| 02/17/2011 | US20110038891 Novel lactic acid bacterium having anti-allergic activity, anti-allergic agent, food and pharmaceutical composition each comprising the lactic acid bacterium, and process for production of the anti-allergic agent |
| 02/17/2011 | US20110038890 Cellular And Viral Inactivation |
| 02/17/2011 | US20110038888 Adjuvant compositions comprising poly-ic and a cationic polymer |
| 02/17/2011 | US20110038887 Novel Vaccine Against Trypanosoma Cruzi Infection |
| 02/17/2011 | US20110038886 N-Linked Glycosylation Alteration in E0 and E2 Glycoprotein of Classical Swine Fever Virus and Novel Classical Swine Fever Virus Vaccine |
| 02/17/2011 | US20110038884 Immunopotentiating agent comprising ep1 agonist |
| 02/17/2011 | US20110038883 He4 monoclonal antibodies and methods for their use |
| 02/17/2011 | US20110038881 Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation |
| 02/17/2011 | US20110038880 Parasporin-1 receptor and use thereof |
| 02/17/2011 | US20110038879 Immunogenic and therapeutic compositions for streptococcus pyogenes |
| 02/17/2011 | US20110038878 Antibodies to il-17a |
| 02/17/2011 | US20110038877 Interleukin-6 antagonists |
| 02/17/2011 | US20110038876 Heterocyclic compounds and use thereof as erk inhibitors |